{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:10:00Z","timestamp":1792602600342,"version":"4.5.0"},"reference-count":37,"publisher":"Xia & He Publishing","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.xiahepublishing.com"],"crossmark-restriction":false},"short-container-title":["J Clin Transl Hepatol"],"published-print":{"date-parts":[[2022,2,28]]},"DOI":"10.14218\/jcth.2021.00089","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T04:11:10Z","timestamp":1625112670000},"page":"6-16","update-policy":"https:\/\/doi.org\/10.14218\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study"],"prefix":"10.14218","volume":"10","author":[{"given":"Cheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-3949","authenticated-orcid":false,"given":"Minzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-1723","authenticated-orcid":false,"given":"Yana","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"4","key":"key20210701040833_JCTH-D-21-00089-b1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","article-title":"Pathological features of fatty liver disease","volume":"147","author":"Yeh","year":"2014","journal-title":"Gastroenterology"},{"issue":"21","key":"key20210701040833_JCTH-D-21-00089-b2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"key20210701040833_JCTH-D-21-00089-b3","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"Jama"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"key20210701040833_JCTH-D-21-00089-b5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"key20210701040833_JCTH-D-21-00089-b6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"key20210701040833_JCTH-D-21-00089-b7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int"},{"issue":"7","key":"key20210701040833_JCTH-D-21-00089-b8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"key20210701040833_JCTH-D-21-00089-b9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"key20210701040833_JCTH-D-21-00089-b11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"issue":"10","key":"key20210701040833_JCTH-D-21-00089-b12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2036.2008.03672.x","article-title":"nonalcoholic fatty liver disease and hepatitis C virus-partners in crime","volume":"27","author":"Blonsky","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"key20210701040833_JCTH-D-21-00089-b13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jceh.2017.01.112","article-title":"Can alcoholic liver disease and nonalcoholic fatty liver disease co-exist?","volume":"7","author":"Mehta","year":"2017","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"key20210701040833_JCTH-D-21-00089-b14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"key20210701040833_JCTH-D-21-00089-b16","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/liv.14750","article-title":"Re: Fouad Y, et al. The NAFLD-MAFLD debate: eminence versus evidence","volume":"41","author":"Sierra","year":"2021","journal-title":"Liver Int"},{"issue":"6","key":"key20210701040833_JCTH-D-21-00089-b17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What\u2019s in a name? renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"key20210701040833_JCTH-D-21-00089-b18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/liv.14788","article-title":"From NAFLD to MAFLD: nurse and allied health perspective","volume":"41","author":"Clayton","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2468-1253(20)30294-6","article-title":"Redefining fatty liver disease: an international patient perspective","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"key20210701040833_JCTH-D-21-00089-b20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2468-1253(20)30340-X","article-title":"The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease","volume":"6","author":"Mendez-Sanchez","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"key20210701040833_JCTH-D-21-00089-b22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2021.01.015","article-title":"The sub-Saharan Africa position statement on the redefinition of fatty liver disease: from NAFLD to MAFLD","volume":"74","author":"Spearman","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2468-1253(20)30213-2","article-title":"Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"key20210701040833_JCTH-D-21-00089-b24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"key":"key20210701040833_JCTH-D-21-00089-b25","doi-asserted-by":"crossref","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"key":"key20210701040833_JCTH-D-21-00089-b26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease","author":"Wai-Sun Wong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"key20210701040833_JCTH-D-21-00089-b27","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/ijerph17061818","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in Xinxiang, China","volume":"17","author":"Li","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"key20210701040833_JCTH-D-21-00089-b28","first-page":"1095","article-title":"Cohort Profile: The China Metal-Exposed Workers Cohort Study (Jinchang Cohort)","volume":"46","author":"Bai","year":"2017","journal-title":"Int J Epidemiol"},{"key":"key20210701040833_JCTH-D-21-00089-b29","unstructured":"World Health Organization. The Asia Pacific Perspectives: redefining obesity and its treatment. World Health Organization 2000. Available from: https:\/\/www.worldobesity.org\/asiapacific"},{"issue":"6","key":"key20210701040833_JCTH-D-21-00089-b30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"key20210701040833_JCTH-D-21-00089-b31","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes care"},{"key":"key20210701040833_JCTH-D-21-00089-b32","article-title":"Chinese guidelines for prevention and treatment of dyslipidemia in adults (2016 Revision)","author":"Chinese Joint Committee","journal-title":"Chinese Journal of Cardiology 2016;31:937-952(in Chinese)"},{"key":"key20210701040833_JCTH-D-21-00089-b33","article-title":"Prevalence and component analysis of metabolic syndrome in Jinchang cohort","author":"Peng","journal-title":"Journal of Lanzhou University (Medical Sciences) 2015;41:54-58(in Chinese)"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab"},{"issue":"1","key":"key20210701040833_JCTH-D-21-00089-b35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"key20210701040833_JCTH-D-21-00089-b36","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"key20210701040833_JCTH-D-21-00089-b37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.clnu.2018.08.008","article-title":"Lean non-alcoholic fatty liver disease","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Nutr"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:20:24Z","timestamp":1783707624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,21]]},"published-print":{"date-parts":[[2022,2,28]]}},"alternative-id":["10.14218\/JCTH.2021.00089"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00089","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}